NCT00433225View on ClinicalTrials.gov

Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Macula Thickening
Interventions
DRUG

Prednisolone Acetate

DRUG

Ketorolac 0.4%

DRUG

Gatifloxacin 0.3%

Trial Locations (1)

11570

Ophthalmic Consultants of Long Island, Rockville Centre

Sponsors

Lead Sponsor

Innovative Medical
All Listed Sponsors
lead

Innovative Medical

INDUSTRY